The Pharmacovigilance Programme of India (PvPI) is an Indian government organization which identifies and responds to drug safety problems.
[1] The Central Drugs Standard Control Organisation established the program in July 2010 [1][2] with All India Institute of Medical Sciences, New Delhi as the National Coordination Centre, which later shifted to Indian Pharmacopoeia Commission in Ghaziabad on 15 April 2011.
[3][4] The establishment of the Pharmacovigilance Program made India a more attractive international destination for foreign companies to bring clinical trials research.
[7][2] As a collaborating center, the Pharmacovigilance Programme assists the WHO in developing international policy for other countries to manage their own drug safety programs.
[7] While the United States and Europe have pharmacovigilance systems which are developed well in some ways, the Indian programme has more and specialized expertise to apply for the unique circumstances of India.